Analysis of laryngeal framework surgery: 10-year follow-up to a national survey
โ Scribed by VyVy N. Young; Thomas G. Zullo; Clark A. Rosen
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 644 KB
- Volume
- 120
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
Objectives:
Laryngeal framework surgery, including medialization laryngoplasty (ML) and arytenoid adduction (AA), are common treatments for vocal fold paralysis and glottal incompetence. Little information is known about the incidence of ML/AA surgery nationwide, in particular the success and complication rates.
Methods:
A 25โitem questionnaire was mailed to 6,644 Boardโcertified otolaryngologists.
Results:
The response rate was 25.7% (n = 1,707). Sixtyโthree percent perform ML and/or AA, representing 29,748 procedures. Experience with Silastic medialization implants has decreased over time, while utilization of other materials has increased. The overall complication rate was 15%, including 0.8% implant extrusion and 6% revision rates. The most common revision was placement of a larger implant (37% of all revisions). Airway compromise requiring intervention was observed in 2.2%, and suboptimal voice outcome in 4%. Although not statistically significant, a trend was observed of decreasing complication rate with increasing experience.
Conclusions:
Laryngeal framework surgeries are being performed with increasing frequency in the United States. The overall complication rate is slightly increased in the present study, but airway compromise and poor vocal outcome are decreased, and the need for revision surgery is unchanged. These findings suggest a continued high level of efficacy of these procedures. Laryngoscope, 2010
๐ SIMILAR VOLUMES
## Abstract ## BACKGROUND The current study was performed to assess whether sequential potentially noncrossโresistant chemotherapy prolongs diseaseโfree survival (DFS) and overall survival (OS) in patients with operable breast carcinoma. ## METHODS Seven hundred eightyโnine patients were registe
A group of 40 individuals were restudied at a median follow-up time of 18 years after chest surgery, chest irradiation, or cyclophosphamide treatment. Their median age at diagnosis was 4.5 years. Nineteen subjects were operated on in the chest area. Radiotherapy of the chest had been used in 21 and